To cite this paper use one of the standards below:
Cisplatin is the one of the most used therapy in oral cancer, and several patients develop resistance. We established cell lines resistant to cisplatin aiming to understanding biological differences driving the progression of oral cancers after treatment. Two cell lines, CAL27 and SCC9 were assessed to establish cisplatin-resistant cell lines through the exposure to different concentrations and time courses of cisplatin. We demonstrated that cellular proliferation, migration and clonogenic capability increased with the resistance levels. Cisplatin administration had not effect over the viability of resistant cell lines. EMT was observed by loss of E-cadherin, gain of Vimentin and the conversion from a cuboidal-epithelial structure into an elongated mesenchymal shape as evidenced by pan-keratin staining. CSC accumulation increased in resistant cell lines. EMT is relevant to the acquisition and maintenance of CSC and is sufficient to endow differentiated cancer cells with stem cell properties, having implications in tumor progression, aggressiveness and resistance to therapy.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper